Hopes of ending the emergency: a critical time for the NHS
Amid record A&E waiting times, hard-working frontline NHS staff feel disillusioned and overwhelmed. Health Secretary Steve Barclays…
UK Life Sciences & Healthcare Industry in 2022: An ever-optimistic tale
In this article, SJ Leatherdale, Partner and Head of our Life Sciences & Healthcare Practice, reflects on observations from…
The evident fast track in Digital Transformation across the Healthcare Sectors – Insights from the Odgers Interim Healthcare Practice
SJ Leatherdale, Partner and Head of our Healthcare & Life…
Leading a disparate workforce: Lessons from the life sciences industry
Ross Gordon, Life Sciences Consultant, speaks to experienced leaders in the life sciences industry to gain their insights…
Digital revolution: what the Topol Review means for NHS senior leadership
SJ Leatherdale, Partner and Head of our Health and Life Sciences Practice explains how the Topol Review will impact senior…
Life Sciences businesses engage interim managers to navigate industry turbulence
Fledgling businesses in the life sciences sector have long struggled with the financial demands that are needed to…
Life Sciences look to interims to deliver ambitions
We look at specialist roles emerging in the Life Sciences sector as the Brexit vote challenges the industry's growth ambitions.
The UK is a global…
Innovation: the true spirit of Life Sciences
Some companies change the world. Today that mission is as clear for the likes of Tesla and Google as it was generations ago for Ford or General…
The status quo and trends in life sciences
The “new normal” of expiring patents, shrinking pipelines, fewer billion dollar blockbusters, generic competition, pricing pressures, increased regulatory…
Guest interview with Thomas Gageik, a specialist in IT
In this interview, we talk to Thomas Gageik, a specialist in IT, about projects and career milestones since becoming an interim.
Thomas, firstly…
